NovaXS Biotech

Nova Xs Biotech

Biotechnology, 2150 Shattuck Ave., Berkeley, California, 94704, United States, 1-10 Employees

novaxs.co

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +19*********

Who is NOVAXS BIOTECH

Led by a professional team in healthcare with a proven track record of over 40 million fundraising experience and 5 successful busines exits, NovaXS Biotech is on a mission to optimize pa...

Read More

map
  • 2150 Shattuck Ave., Berkeley, California, 94704, United States Headquarters: 2150 Shattuck Ave., Berkeley, California, 94704, United States
  • 2021 Date Founded: 2021
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 3841 | NAICS Code: 339112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from NOVAXS BIOTECH

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding NovaXS Biotech

Answer: NovaXS Biotech's headquarters are located at 2150 Shattuck Ave., Berkeley, California, 94704, United States

Answer: NovaXS Biotech's phone number is +19*********

Answer: NovaXS Biotech's official website is https://novaxs.co

Answer: NovaXS Biotech's revenue is Under $1 Million

Answer: NovaXS Biotech's SIC: 3841

Answer: NovaXS Biotech's NAICS: 339112

Answer: NovaXS Biotech has 1-10 employees

Answer: NovaXS Biotech is in Biotechnology

Answer: NovaXS Biotech contact info: Phone number: +19********* Website: https://novaxs.co

Answer: Led by a professional team in healthcare with a proven track record of over 40 million fundraising experience and 5 successful busines exits, NovaXS Biotech is on a mission to optimize patients medication self-administration experience and improve treatment outcomes. Our patent-pending technology, Telosis, is a patient-centric closed-loop drug delivery bio pharma solution that helps patients deliver medications subcutaneously or intramuscularly without a needle and manage their chronic condition and medication adherence on the patient engagement APP. The technology could also help pharmaceutical partners reduce their COG by 30%, increase revenue with improved patient compliance, and boost efficacy of medication with better absorption rate. Current partners and investors include Baxter, Edward-Elmhurst Health, Helixmith, etc.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access